A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts.
Clarhaut J, Fraineau S, Guilhot J, Peraudeau E, Tranoy-Opalinski I, Thomas M, Renoux B, Randriamalala E, Bois P, Chatelier A, Monvoisin A, Cronier L, Papot S, Guilhot F.
Clarhaut J, et al. Among authors: papot s.
Leuk Res. 2013 Aug;37(8):948-55. doi: 10.1016/j.leukres.2013.04.026. Epub 2013 May 28.
Leuk Res. 2013.
PMID: 23726264